Brief: ImmuCell Q1 Loss Per Share $0.02
13/05/2020 22:08
May 13 (Reuters) - ImmuCell Corp ICCC.O :
* IMMUCELL ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE
FIRST
QUARTER ENDED MARCH 31, 2020
* Q1 LOSS PER SHARE $0.02
* QTRLY TOTAL PRODUCT SALES INCREASED BY 11%, OR $500,000,
TO $4.9
MILLION
Source text for Eikon: ID:nGNX6YKXh8
Further company coverage: ICCC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year